In clinical use cardioplegia is usually combined with local cardiac hypothermia, whose
powerful protective effects make it difficult to assess the contributions made by the …

In a rat heart model of cardiopulmonary bypass and ischemic cardiac arrest the potential
additive protective effects of hypothermia and chemical cardioplegia have been …

Both single-dose and multidose cardioplegia are protective in the ischemic adult heart under
normothermic and hypothermic conditions, but in the hypothermic neonatal rabbit heart …

The rationale for cold saline induced hypothermic myocardial protection during ischemic
cardioplegia has been limited for the most part to empiric and contractility observations. The …

This study tests the hypothesis that the efficacy of cardioplegic solution depends upon its
chemical constituents rather than on its temperature alone. A standard preparation of right …

The ideal temperature and hematocrit level of blood cardioplegia has not been clearly
established. This study was undertaken (a) to determine the optimal temperature of blood …

The aim of this study was to determine the temperature for optimal myocardial preservation
during cardioplegic arrest. In isolated canine hearts perfused by a support dog, functional …

This study was performed to determine if systemic temperature affects the rate of cooling and
rewarming of the myocardium between infusions of cold potassium cardioplegic solution …

Cold chemical cardioplegia is currently the method of choice for providing a still, relaxed and
unobstructed operating field during open heart surgery. This procedure involves aortic cross …

Following animal experiments, intraoperative protection of the myocardium was used
clinically. It consisted of an initial cardiac arrest, according to the method of Kirsch, and …